Neovantage Bio-Technology Private Limited - Company Profile

It is a financial services private limited company based in Hyderabad, Telangana, India, established in 2016.
2016 Hyderabad, Telangana, India Amalgamated
Last Updated:
Access Report
About Neovantage Bio-Technology Private Limited

Neovantage Bio-Technology Private Limited, a amalgamated private limited company, was established on 09 July 2016 in Hyderabad, Telangana, India. Engaging in real estate financing within the construction sector, it holds CIN: U74999TG2016PTC110776. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹12.50 Cr and a paid-up capital of ₹9.82 Cr.

It upholds a compliant status. Its leadership includes Shilpi Chowdhary (Director), Chandan Kumar Mishra (Additional Director). Past directors included Amrendra Kumar Singh, Barbie Saurabhkumar Singh, Rajesh Sundaresan. It holds ₹63.00 Cr open charges and ₹361.60 Cr settled loans. Its latest AGM occurred on 26 September 2024, with the balance sheet filed on 31 March 2024. It is based at Building-450, Genome Valley, Turkapally (V), Shamirpet Mandal, Hyderabad, Telangana, 500078.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999TG2016PTC110776

  • Registration Number

    110776

  • Incorporation Date

    09 July 2016

  • Authorized Capital

    ₹12.50 Cr

  • Paid-Up Capital

    ₹9.82 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 12.50 Cr
  • Paid Up Capital ₹ 9.82 Cr
  • Company Age 9 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 63.00 Cr
  • Satisfied Charges ₹ 361.60 Cr
  • Revenue Growth **** 146.35%
  • Profit Growth **** -21.34%
  • Ebitda **** 114.08%
  • Net Worth -22.21%
  • Total Assets -8.00%
Company report

Neovantage Bio-Technology Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Neovantage Bio-Technology Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Neovantage Bio-Technology Private Limited?
Current Directors
Name Designation Appointment Date Status
Shilpi Chowdhary Director 10 Jul 2018 Current
Chandan Kumar Mishra Additional Director 17 Oct 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Ceo(Kmp) 08 Mar 2019 Past
Pramod Abcsdd Company Secretary 03 May 2018 Past
Pramod Abcsdd Director 24 Sep 2020 Past
Pramod Abcsdd Director 19 Sep 2016 Past
Pramod Abcsdd Director 10 Jul 2018 Past
Pramod Abcsdd Additional Director 30 Sep 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Neovantage Bio-Technology.

Neovantage Bio-Technology Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 146.35% increase. The company also saw a substantial fall in profitability, with a 21.34% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.21%.

Neovantage Bio-Technology revenue growth over time
Neovantage Bio-Technology profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 146.35%
*******
*******
*******
*******
Revenue from Operations
*******
 302.40%
*******
*******
*******
*******
Total Assets
*******
 -8.00%
*******
*******
*******
*******
Profit or Loss
*******
 -21.34%
*******
*******
*******
*******
Net Worth
*******
 -22.21%
*******
*******
*******
*******
EBITDA
*******
 114.08%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Neovantage Bio-Technology?

In 2021, Neovantage Bio-Technology had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹630,000,000.00

Satisfied Charges

₹3,616,000,000.00

Charges Breakdown by Lending Institutions
  • Idbi Trusteeship Services Limited : 222.00 Cr
  • Others : 139.60 Cr
Latest Charge Details
Date Lender Amount Status
17 Dec 2019 Others ₹69.60 Cr Satisfied
07 Sep 2018 Others ₹70.00 Cr Satisfied
27 Sep 2016 Idbi Trusteeship Services Limited ₹54.50 Cr Satisfied
27 Sep 2016 Idbi Trusteeship Services Limited ₹167.50 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Neovantage Bio-Technology?

Unlock and access historical data on people associated with Neovantage Bio-Technology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Neovantage Bio-Technology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neovantage Bio-Technology's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Neovantage Bio-Technology
Recent Activity within the Organization
  • Director Appointment

    Chandan Kumar Mishra was appointed as a Additional Director was appointed as a Additional Director on 17 Oct 2024 & has been associated with this company since 1 year 4 months . was recorded as a recent event.

  • Annual General Meeting

    Neovantage Bio-Technology Private Limited last Annual general meeting of members was held on 26 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Neovantage Bio-Technology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.

  • Charges

    Progress on A charge registered on 17 Dec 2019 via Charge ID 100314853 with Others was fully satisfied on 21 Sep 2022. was documented.

  • Charges

    The activity A charge with Others of Rs. 69.60 Cr registered on 17 Dec 2019 with Charge ID 100314853 was modified on 19 Oct 2020. was completed.

  • Charges

    Progress on A charge registered on 07 Sep 2018 via Charge ID 100203201 with Others was fully satisfied on 17 Jan 2020. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Neovantage Bio-Technology Private Limited?

The CIN of Neovantage Bio-Technology Private Limited is U74999TG2016PTC110776.

Where is Neovantage Bio-Technology Private Limited headquartered?

Neovantage Bio-Technology Private Limited is headquartered at Building-450, Genome Valley, Turkapally (V), Shamirpet Mandal, Hyderabad, Telangana, 500078.

When was Neovantage Bio-Technology Private Limited incorporated?

Neovantage Bio-Technology Private Limited was incorporated on 09 July 2016.

Who are the current directors of Neovantage Bio-Technology Private Limited?

The current directors of Neovantage Bio-Technology Private Limited are

What is the primary industry of Neovantage Bio-Technology Private Limited?

The primary industry of Neovantage Bio-Technology Private Limited is Construction.

Is Neovantage Bio-Technology Private Limited a listed company?

Neovantage Bio-Technology Private Limited is unlisted.

What is the capital structure of Neovantage Bio-Technology Private Limited?

The authorized capital of Neovantage Bio-Technology Private Limited is ₹12.50 Cr, and the paid-up capital is ₹9.82 Cr.

What is the compliance status of Neovantage Bio-Technology Private Limited?

The compliance status of Neovantage Bio-Technology Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available